Clinical Trials Directory

Trials / Completed

CompletedNCT02635893

Lower Limb Function After Spinal Cord Injury

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
257 (actual)
Sponsor
Shirley Ryan AbilityLab · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This is a randomized, experimental study that examines the physiology of central nervous system pathways contributing to the control of bilateral movements in individuals with spinal cord injuries and promotes the recovery of lower-limb motor function through the use of stimulation and locomotor training.

Detailed description

This study plans to examine plasticity in corticospinal synapses of lower-limb muscles. it has been demonstrated that plasticity elicited at corticospinal synapses in the spinal cord result in enhancements in electromyographic (EMG) and force activity in upper-limb muscles. The first step in this proposal is to determine if synaptic plasticity can be elicited in corticospinal projections targeting lower-limb muscles in humans with SCI. We will also study methods to strengthen corticospinal plasticity to promote recovery of leg clearance during training. We will use two novel strategies to enhance plasticity in corticospinal synapses of lower-limb muscles after SCI: a). administration of an N-methyl-D-aspartate (NMDA) receptor agonist (i.e. D-cycloserine), and b). Combine NMDA-induced corticospinal plasticity with training (2D lower limb training and locomotor training. Corticospinal synaptic plasticity is thought to depend on activation of NMDA receptors and D-cycloserine enhances motor skill behaviors in animals and humans will be enhanced by NMDA-induced corticospinal plasticity. An important strength of this aim is the combination of training and strategies that aimed at enhancing the synaptic efficacy of residual corticospinal projections. Training effects on physiological pathways will be explored and correlated with locomotor function

Conditions

Interventions

TypeNameDescription
DRUGD-Cycloserine100 mg of Seromycin by mouth will be administered
DRUGPlaceboplacebo pill will be administered instead of medication by mouth
OTHERTrainingwalking around a designated track at different speeds both forward and backward
OTHERStimulationmagnetic stimulation and electrical stimulation may be applied
OTHERPlacebo Stimulationthis is a fake stimulation that is administered but will be unknow to the subject.

Timeline

Start date
2019-06-21
Primary completion
2021-03-09
Completion
2021-04-11
First posted
2015-12-21
Last updated
2021-07-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02635893. Inclusion in this directory is not an endorsement.